Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Syndax Pharmaceuticals (SNDX) over the last 1 years, with Q1 2020 value amounting to $19.7 million.

  • Syndax Pharmaceuticals' Long-Term Debt Issuances changed N/A to $19.7 million in Q1 2020 from the same period last year, while for Dec 2020 it was $19.7 million, marking a year-over-year change of. This contributed to the annual value of $19.7 million for FY2020, which is N/A changed from last year.
  • Per Syndax Pharmaceuticals' latest filing, its Long-Term Debt Issuances stood at $19.7 million for Q1 2020.
  • Over the past 5 years, Syndax Pharmaceuticals' Long-Term Debt Issuances peaked at $19.7 million during Q1 2020, and registered a low of $19.7 million during Q1 2020.